Abstract
A cell culture model of the blood-brain barrier (BBB) consisting of a coculture of bovine brain capillary endothelial cells and rat astrocytes has been used to examine the ability of 60-nm nanoparticles with different physicochemical characteristics to cross the BBB. Neutral, anionic, and cationic nanoparticles were made from crosslinked malto-dextrins derivatized or not (neutral) with phosphates (anionic), quaternary ammoniums (cationic) ligands. Then, these particles were coated or not with a lipid bilayer made of dipalmitoyl phosphatidyl choline and cholesterol. Lipid coating of ionically charged nanoparticles was able to increase BBB crossing 3- or 4-fold compared with uncoated particles, whereas coating of neutral particles did not significantly alter their permeation characteristics across the endothelial cell monolayer. Lipid-coated nanoparticles were nontoxic toward BBB integrity, and crossed the BBB by transcytosis without any degradation. Furthermore, a 27-fold increase in albumin transport was observed when albumin had previously been loaded in the cationic lipid-coated nanoparticles. The influence of red blood cells was studied; a marked inhibition of the transport was observed, probably due to strong interaction between nanoparticles and red blood cells.
Footnotes
-
Send reprint requests to: Roméo Cecchelli, Unité mixte Institut Pasteur-Université d'Artois, Faculté des sciences Jean-Perrin, 62307 Lens, France. E-mail:romeo.cecchelli{at}pasteur-lille.fr
-
↵1 Current address: Biovector Therapeutics, Chemin du Chêne vert, BP 169, 31676 Labège cedex, France.
-
↵2 Current address: Institut National de la Santé et de la Recherche Médicale U325, Département d'Athérosclérose, Institut Pasteur de Lille, 59019 Lille, France.
- Abbreviations:
- BBB
- blood-brain barrier
- EC
- endothelial cell
- L-BV
- light biovector
- PC
- polysaccharide core
- QAE
- cationic
- N
- neutral
- P
- anionic
- LDL
- low-density lipoprotein
- Received June 7, 1999.
- Accepted August 17, 1999.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|